Schedule 13G ownership disclosure
Protara Therapeutics Inc
Common Stock, par value $0.001 per share · CUSIP: 74365U107
Event date: 2024-12-31
- Filing-level shares
- 1,331,258.00
- Percent of class
- 3.9%
- Woodline Partners LP
Shares: 1,331,258.00 · Class: 3.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-001020
- Form type
- SCHEDULE 13G/A
- Filer
- Protara Therapeutics, Inc.
- CIK
- CIK 1359931
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership